Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
10676
CALL
ALX Oncology
ALXO
$160M
| $130K | ﹤0.01% |
71,600
+36,800
| +106% | +$137K |
2021 Q1
14 quarters
|
|
|
DAO
10677
Youdao
DAO
$2.02B
| $130K | ﹤0.01% |
31,393
-1,272
| -4% | -$4.36K |
2024 Q2
1 quarter
|
|
10678
PUT
Ocugen
OCGN
$338M
| $130K | ﹤0.01% |
131,300
-32,900
| -20% | -$45.2K |
2021 Q1
14 quarters
|
|
10679
PUT
Xeris Biopharma Holdings
XERS
$1.87B
| $130K | ﹤0.01% |
45,700
+700
| +2% | +$1.8K |
2020 Q1
18 quarters
|
|
10680
CALL
ReNew
RNW
$2.51B
| $130K | ﹤0.01% |
20,700
+8,000
| +63% | +$47.4K |
2021 Q3
12 quarters
|
|
10681
CALL
Stock Yards Bancorp
SYBT
$2.37B
| $130K | ﹤0.01% |
2,100
-1,200
| -36% | -$69.2K |
2023 Q3
4 quarters
|
|
|
FFIC
10682
DELISTED
Flushing Financial
FFIC
| $130K | ﹤0.01% |
8,926
-67,469
| -88% | -$949K |
2023 Q4
3 quarters
|
|
|
BRT
10683
CALL
BRT Apartments
BRT
$255M
| $130K | ﹤0.01% |
7,400
-31,800
| -81% | -$578K |
2022 Q1
10 quarters
|
|
10684
PUT
CVB Financial
CVBF
$3.82B
| $130K | ﹤0.01% |
7,300
+4,700
| +181% | +$83.8K |
2023 Q1
6 quarters
|
|
10685
CALL
Alpha Pro Tech
APT
$58.5M
| $130K | ﹤0.01% |
22,800
+17,100
| +300% | +$98.9K |
2020 Q1
18 quarters
|
|
10686
PUT
Invesco DB Oil Fund
DBO
$290M
| $130K | ﹤0.01% |
9,300
-21,500
| -70% | -$320K |
2022 Q4
7 quarters
|
|
|
KE
10687
Kimball Electronics
KE
$683M
| $130K | ﹤0.01% |
7,012
-14,868
| -68% | -$297K |
2021 Q4
11 quarters
|
|
|
AVNS
10688
CALL
DELISTED
Avanos Medical
AVNS
| $130K | ﹤0.01% |
5,400
+4,600
| +575% | +$105K |
2022 Q4
7 quarters
|
|
10689
CALL
Brookdale Senior Living
BKD
$2.61B
| $130K | ﹤0.01% |
19,100
-4,700
| -20% | -$33.5K |
2022 Q4
7 quarters
|
|
|
RPC
10690
PUT
Ridgepost Capital
RPC
$866M
| $130K | ﹤0.01% |
12,100
+8,100
| +203% | +$79.6K |
2022 Q4
7 quarters
|
|
10691
ITT
ITT
$17.6B
| $129K | ﹤0.01% |
866
-44,697
| -98% | -$6.08M |
2024 Q1
2 quarters
|
|
10692
PUT
The RMR Group
RMR
$302M
| $129K | ﹤0.01% |
5,100
-11,900
| -70% | -$294K |
2023 Q1
6 quarters
|
|
10693
PUT
Erasca
ERAS
$5.23B
| $129K | ﹤0.01% |
47,400
-38,700
| -45% | -$109K |
2022 Q4
7 quarters
|
|
|
LAND
10694
CALL
Gladstone Land Corp
LAND
$414M
| $129K | ﹤0.01% |
9,300
+500
| +6% | +$7.04K |
2020 Q4
15 quarters
|
|
10695
PUT
MeiraGTx Holdings
MGTX
$1.01B
| $129K | ﹤0.01% |
31,000
+300
| +1% | +$1.3K |
2022 Q3
8 quarters
|
|
10696
PUT
Zymeworks
ZYME
$1.81B
| $129K | ﹤0.01% |
10,300
+1,900
| +23% | +$20.7K |
2022 Q4
7 quarters
|
|
10697
Invesco DB US Dollar Index Bearish Fund
UDN
$102M
| $129K | ﹤0.01% |
6,824
+6,632
| +3,454% | +$123K |
2024 Q2
1 quarter
|
|
10698
PUT
Insight Enterprises
NSIT
$4.76B
| $129K | ﹤0.01% |
600
+500
| +500% | +$103K |
2022 Q4
7 quarters
|
|
10699
CALL
HNI Corp
HNI
$3.41B
| $129K | ﹤0.01% |
2,400
+400
| +20% | +$20.3K |
2022 Q4
7 quarters
|
|
10700
Brookfield Infrastructure Partners
BIP
$17B
| $129K | ﹤0.01% |
3,681
-219,737
| -98% | -$6.9M |
2021 Q1
14 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.